Lithium Ion

Lithium Ion

SCHEMBL3640204

COC(=O)NCCOC(c1ccc(C)cc1)c1cccc(C(=O)[O-])c1.[Li+]

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.40
HTR1A P08908 2/20 0.37
ADRA1D P25100 2/20 0.37
ADRA1A P35348 2/20 0.37
ADRA1B P35368 2/20 0.37
POLB P06746 1/20 0.37
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LTB4R Q15722 3/20 0.36
ALDH1A1 P00352 1/20 0.35
PKM P14618 1/20 0.35
HTT P42858 1/20 0.34
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL3343498 0.92 REN (0.39) HTR1AADRA1DADRA1AADRA1BPOLB
Lithium Ion SCHEMBL3338747 0.92 HTR1A (0.44) HTR1AADRA1DADRA1AADRA1BHPGD
SCHEMBL3643578 0.89 CASR (0.42) GAAHTR1AADRA1DADRA1AADRA1B
SCHEMBL8076505 0.82 HTR1A (0.46) HTR1AADRA1DADRA1AADRA1BHPGD
SCHEMBL3641253 0.81 ALDH1A1 (0.41) HTR1AADRA1DADRA1AADRA1BPOLB
SCHEMBL3344191 0.81 CASR (0.42) POLB
SCHEMBL3343494 0.81 CASR (0.49) HTR1AADRA1DADRA1AADRA1BHPGD
SCHEMBL3338753 0.81 HTR1A (0.46) HTR1AADRA1DADRA1AADRA1BHPGD
SCHEMBL3343503 0.80 ALDH1A1 (0.40) HTR1AADRA1DADRA1AADRA1BPOLB
SCHEMBL1567463 0.76 HTT (0.45) HPGDSMN1; SMN2ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2170815-A2 RENIN INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2010-04-07 EP disclosed
WO-2008156817-A2 RENIN INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2008-12-24 WO disclosed